论文部分内容阅读
应用骨髓腔与静脉内联合化疗治疗急性白血病21例,其中男性14例,女性7例。年龄为14～56岁(平均27.2),含急性粒细胞性白血病(急粒)6例,慢性粒细胞白血病急粒变(慢粒急粒变)1例,红白血病1例,急性早幼粒细胞白血病2例,急性单核细胞性白血病(急单)1例。急性淋巴细胞性白血病(急淋)10例。 方法 诱导缓解以HOADP和COADP方案为基础方案,配合支持疗法,缓解后巩固1～2个疗程,鞘内注射2～3次预防胸膜白血病。 1.急非淋:静脉及骨髓腔内均用HOA-DP方案。见附表。
Application of marrow cavity and intravenous chemotherapy in 21 cases of acute leukemia, including 14 males and 7 females. Aged 14 to 56 years old (mean 27.2), including acute myeloid leukemia (acute pellet) in 6 cases, chronic myeloid leukemia acute pelleting (CAG) in 1 case, erythroleukemia in 1 case, acute promyelocytic 2 cases of cell leukemia, acute monocytic leukemia (urgent single) in 1 case. Acute lymphoblastic leukemia (acute lymphoblastic) in 10 cases. Methods Induction of remission HOADP and COADP regimen as the basis for the program, with supportive therapy, remission to consolidate 1 to 2 courses of treatment, intrathecal injection of 2 to 3 times to prevent pleural leukemia. 1. Urgent injection: vein and marrow cavity are used HOA-DP program. See Schedule.